In recent years, the pharmaceutical industry has shown significant interest in improved alternatives to ‘small molecules’ for medication discovery. Within this strategic direction, cyclopeptidic compounds are gaining traction in drug discovery, medicinal chemistry, and materials science. As explained by researcher Arkaitz Correa from the University of the Basque Country’s Faculty of Chemistry, unlike small molecules…
